MSRPS
ALXN

Maryland State Retirement & Pension System’s Alexion Pharmaceuticals ALXN Stock Holding History

Maryland State Retirement & Pension System’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,447
Closed -$3.04M – 1523
2021
Q2 		$3.04M Buy
16,447
+177
+1% +$30.4K 0.1% 193
2021
Q1 		$2.49M Buy
16,270
+12,838
+374% +$1.99M 0.09% 227
2020
Q4 		$537K Buy
+3,432
New +$441K 0.1% 207

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Maryland State Retirement & Pension System's ALXN Position: Q3 2021 in Review

Maryland State Retirement & Pension System sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 16,447 shares — an estimated $3.04M sold.

Maryland State Retirement & Pension System first reported a position in ALXN in Q4 2020 and held it in 3 quarters. The position peaked at $3.04M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Maryland State Retirement & Pension System reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 16,447 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3.04M.
  • Maryland State Retirement & Pension System first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Maryland State Retirement & Pension System's Alexion Pharmaceuticals position peaked at $3.04M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Maryland State Retirement & Pension System's 13F filing for Q3 2021, filed 29 Oct 2021.